Most Read Articles
Roshini Claire Anthony, 5 days ago

A genotype-guided approach to warfarin dosing may result in fewer dose adjustments in Asian patients, according to a study from Singapore.

10 Aug 2018

Fungal microbiome, also called the mycobiome, appears to be highly variable in patients with well-characterized fungal diseases, a recent study has shown. Moreover, severe asthmatics have the highest fungal loads, along with those receiving steroid and antifungal therapy.

Tristan Manalac, 6 days ago
The risk of complicated appendicitis is lower in children with IgE-mediated allergy, according to a recent study.
21 Jul 2018
Although many patients with atopic dermatitis (AD) use antihistamines, no high-level evidence exists to prove that nonsedating antihistamines reduce itch in patients with AD or provide benefit in controlling AD symptoms, except perhaps sleep and AD comorbidities such as allergic rhinitis, according to a study.

CPAP treatment falls short of improving asthma control in patients with concomitant OSAS

09 Aug 2018

Continuous positive airway pressure (CPAP) treatment offers little benefit to asthmatic patients with obstructive sleep apnoea syndrome (OSAS), with a recent study showing that the intervention does not improve asthma control.

On the other hand, CPAP may attenuate daytime sleepiness, as well as enhance asthma-related quality of life and vitality.

A total of 122 patients with nocturnal asthma symptoms despite treatment with at least moderate‐dose inhaled corticosteroid and long‐acting bronchodilators underwent a home sleep study using a portable diagnostic system. Forty-one patients (33.6 percent) were found to have significant OSAS (apnoea–hypopnoea index [AHI] ≥10/h), among whom 37 were randomized to receive either CPAP (n=17) or conservative treatment (n=20) for 3 months.

Relative to those who did not have the sleep apnoea, OSAS patients had higher body mass index (mean, 27.4 vs 25.1 kg/m2; p=0.016), bigger neck circumference (mean, 36.6 vs 34.8 cm; p=0.006) and lower minimum SaO2 (mean, 80.7 vs 87.2 percent; p<0.001).

CPAP treatment did not produce a significant change in Asthma Control Test score compared with conservative treatment (mean, 3.2 vs 2.4; p=0.568) at month 3. However, CPAP-treated patients showed notable improvements in Epworth Sleepiness Scale (mean, −3.0 vs 0.5; p=0.014), Asthma Quality of Life Questionnaire (mean, 0.6 vs 0.02; p=0.022) and SF‐36 questionnaire vitality domain (mean, 14.7 vs 0.3; p=0.012) scores.

Characterized by repetitive episodes of upper airway obstruction, OSAS has been reported to be highly prevalent in asthmatic populations. The sleep apnoea causes intermittent hypoxia, sleep fragmentation, impaired cognitive function and poor health status. [Thorax 2004;59:618-622; J Thorac Dis 2017;9:1945-1958]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 5 days ago

A genotype-guided approach to warfarin dosing may result in fewer dose adjustments in Asian patients, according to a study from Singapore.

10 Aug 2018

Fungal microbiome, also called the mycobiome, appears to be highly variable in patients with well-characterized fungal diseases, a recent study has shown. Moreover, severe asthmatics have the highest fungal loads, along with those receiving steroid and antifungal therapy.

Tristan Manalac, 6 days ago
The risk of complicated appendicitis is lower in children with IgE-mediated allergy, according to a recent study.
21 Jul 2018
Although many patients with atopic dermatitis (AD) use antihistamines, no high-level evidence exists to prove that nonsedating antihistamines reduce itch in patients with AD or provide benefit in controlling AD symptoms, except perhaps sleep and AD comorbidities such as allergic rhinitis, according to a study.